Modulation of Antigen Display on PapMV Nanoparticles Influences Its Immunogenicity

نویسندگان

چکیده

Background: The papaya mosaic virus (PapMV) vaccine platform is a rod-shaped nanoparticle made of the recombinant PapMV coat protein (CP) self-assembled around noncoding single-stranded RNA (ssRNA) template. induces innate immunity through stimulation Toll-like receptors (TLR) 7 and 8. display antigen at surface nanoparticle, associated with co-stimulation signal via TLR7/8, ensures strong immune response, which ideal for development candidate vaccines. In this study, we assess impact where peptide fused, whether or extremities nanoparticles, on response directed to that antigen. Methods: Two different peptides from influenza A were used as model antigens. conserved M2e peptide, derived matrix 2 was chosen B-cell epitope, nucleocapsid cytotoxic T lymphocytes (CTL) epitope. These coupled two positions CP, N- (PapMV-N) C-terminus (PapMV-C), using transpeptidase activity Sortase (SrtA). responses, both humoral CD8+ T-cell-mediated, antigens in fusion contexts analyzed compared. coupling density also investigated. Conclusions: results demonstrate N-terminus CP led an enhanced compared C-terminus. difference between platforms linked capacity PapMV-N stimulate TLR7/8. We demonstrated strength increases nanoparticles.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Conjugation to gold nanoparticles improves antigen immunogenicity

The effectiveness efficacy of a gold nanoparticle delivery system for the the rF1 plague antigen was assessed by immunising mice with a coupled vaccine formulation. In this study, we describe a method for conjugating a capsular protein (F1-antigen) from Yersinia pestis onto gold nanoparticles as a potential delivery vehicle for subunit vaccines. The gold nanoparticles used in the experiment wer...

متن کامل

Gas Vesicle Nanoparticles for Antigen Display

Microorganisms like the halophilic archaeon Halobacterium sp. NRC-1 produce gas-filled buoyant organelles, which are easily purified as protein nanoparticles (called gas vesicles or GVNPs). GVNPs are non-toxic, exceptionally stable, bioengineerable, and self-adjuvanting. A large gene cluster encoding more than a dozen proteins has been implicated in their biogenesis. One protein, GvpC, found on...

متن کامل

Improvement of the Trivalent Inactivated Flu Vaccine Using PapMV Nanoparticles

Commercial seasonal flu vaccines induce production of antibodies directed mostly towards hemaglutinin (HA). Because HA changes rapidly in the circulating virus, the protection remains partial. Several conserved viral proteins, e.g., nucleocapsid (NP) and matrix proteins (M1), are present in the vaccine, but are not immunogenic. To improve the protection provided by these vaccines, we used nanop...

متن کامل

Type VI secretion system sheaths as nanoparticles for antigen display.

The bacterial type 6 secretion system (T6SS) is a dynamic apparatus that translocates proteins between cells by a mechanism analogous to phage tail contraction. T6SS sheaths are cytoplasmic tubular structures composed of stable VipA-VipB (named for ClpV-interacting protein A and B) heterodimers. Here, the structure of the VipA/B sheath was exploited to generate immunogenic multivalent particles...

متن کامل

Engineering of Papaya Mosaic Virus (PapMV) Nanoparticles through Fusion of the HA11 Peptide to Several Putative Surface-Exposed Sites

Papaya mosaic virus has been shown to be an efficient adjuvant and vaccine platform in the design and improvement of innovative flu vaccines. So far, all fusions based on the PapMV platform have been located at the C-terminus of the PapMV coat protein. Considering that some epitopes might interfere with the self-assembly of PapMV CP when fused at the C-terminus, we evaluated other possible site...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Vaccines

سال: 2021

ISSN: ['2076-393X']

DOI: https://doi.org/10.3390/vaccines9010033